Cedar Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,680
Closed -$708K 107
2020
Q3
$708K Buy
5,680
+1,905
+50% +$236K 0.23% 107
2020
Q2
$366K Buy
3,775
+240
+7% +$24.9K 0.14% 127
2020
Q1
$318K Sell
3,535
-91
-3% -$11.8K 0.15% 121
2019
Q4
$536K Buy
3,626
+715
+25% +$96K 0.25% 123
2019
Q3
$351K Buy
2,911
+676
+30% +$87.4K 0.16% 130
2019
Q2
$302K Sell
2,235
-182
-8% -$23K 0.13% 141
2019
Q1
$315K Sell
2,417
-160
-6% -$21.5K 0.14% 135
2018
Q4
$321K Sell
2,577
-730
-22% -$98K 0.16% 123
2018
Q3
$460K Buy
3,307
+1,037
+46% +$129K 0.18% 125
2018
Q2
$233K Buy
+2,270
New +$230K 0.1% 140

Other funds holding HCA

Cedar Capital's HCA Position: Q4 2020 in Review

Cedar Capital sold out of HCA Healthcare (HCA) in Q4 2020, closing a stake of 5,680 shares — an estimated $708K sold.

Cedar Capital first reported a position in HCA in Q2 2018 and held it in 10 quarters. The position peaked at $708K in Q3 2020. 779 funds tracked by Wall St. Rank hold HCA as of Q4 2020.

  • Cedar Capital reported no remaining HCA Healthcare position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 5,680 HCA Healthcare shares in Q4 2020, an estimated $708K.
  • Cedar Capital first reported a position in HCA Healthcare in Q2 2018 and held it in 10 quarters.
  • Cedar Capital's HCA Healthcare position peaked at $708K in Q3 2020.
  • 779 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.